Exosurf Neonatal

Active Ingredient(s): Colfosceril + Cetyl Alcohol + Tyloxapol
FDA Approved: * August 2, 1990
Category: Neonatal (Infant)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Exosurf Neonatal Overview

Pulmonary surfactant is a surface-active lipoprotein complex (phospholipoprotein) formed by type II alveolar cells. The proteins and lipids that make up the surfactant have both hydrophilic and hydrophobic regions. By adsorbing to the air-water interface of alveoli, with hydrophilic head groups in the water and the hydrophobic tails facing towards the air, the main lipid component of surfactant, dipalmitoylphosphatidylcholine (DPPC), reduces surface tension. As a medication, pulmonary surfact...

Read more Exosurf Neonatal Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pulmonary_surfactant

Recent Exosurf Neonatal Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Colfosceril + Cetyl Alcohol + Tyloxapol
  • For Suspension: 12mg/vial + 108mg/vial + 8mg/vial
  • Powder for Reconstitution: 12mg + 108mg + 8mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (1 result)

Related Exosurf Neonatal Topics:

multitrace neonatal
where can i buy this...